Home Evgen Pharma

Evgen Pharma

In operation
Post-IPO Round
Clinical-Stage Drug Developer

Basic Information

Evgen Pharma is a clinical-stage drug development company focused on cancer and neurological diseases. Evgen is developing Sulforadex, a synthetic drug based on sulforaphane, a substance produced in the body after consuming broccoli and other vegetables in the cabbage family, whose anti-cancer benefits are well-documented.
Evgen Pharma PLC
England,United Kingdom
15~50 people
January 01, 2007
enquiries@evgen.com